跳至主要内容
临床试验/NCT01918202
NCT01918202已完成1 期

A Phase 1, Open-label Adaptive Design Study To Evaluate Pde10 Enzyme Occupancy As Measured By Positron Emission Tomography (Pet) Following Single Oral Dose Administration Of Pf-02545920 In Healthy Male Subjects

Pfizer1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
9
试验地点
1
主要终点
Central PDE10A enzyme occupancy values in the striatum.

研究概览

简要总结

This Phase 1 study will evaluate PDE10 enzyme occupancy using Positron Emission Tomography after a single dose of PF-02545920 in Healthy male volunteers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • healthy male volunteers

排除标准

  • History of orthostatic hypotension
  • History of prior radiation exposure for research purposes, or radiation therapy

研究组 & 干预措施

Cohort 1 - 20 mg

Experimental

Cohort will include 4 HVs/completers who will receive a single 20 mg dose of PF-02545920.

干预措施: 20 mg PF-02545920 (Drug)

Cohort 2 ( adaptive dose, optional)

Experimental

Cohort 2 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1.

干预措施: PF-02545920 (Drug)

Cohort 3 ( adaptive dose, optional)

Experimental

Cohort 3 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1.

Dose options range from 30 mg to 10 mg, 5 mg, 2mg, 1 mg. This cohort is optional

干预措施: PF-02545920 (Drug)

结局指标

主要结局

Central PDE10A enzyme occupancy values in the striatum.

时间窗: Day 10

Using Positron Emission Tomography and a radiotracer (MNI-659) for PF-02545920, the central PDE10A enzyme occupancy values will be measured in the striatum at different single oral doses of PF-02545920.

次要结局

  • Central PDE10A enzyme occupancy values in the globus pallidus, in the caudate and in the putamen (separately).(Day 10)
  • Maximum Observed Plasma Concentration (Cmax)(Day 10)
  • Time to Reach Maximum Observed Plasma Concentration (Tmax)(Day 10)
  • Average serum concentration(Day 10)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study To Evaluate The PDE10 Enzyme Occupancy... | 临床试验